Medixine Increases U.S. Expansion, Appoints Local Senior Advisor Peter Alperin

ESPOO, Finland—Finnish health tech company and remote patient monitoring (RPM) platform provider Medixine is continuing its strategic United States market expansion with the appointment of U.S.-based senior advisor Peter Alperin, M.D..

Alperin, an experienced digital medtech developer, will advise on strategic expansion and market positioning, strengthening Medixine’s already established foothold in the U.S., where the company has worked with multiple partners. Alperin’s appointment is Medixine’s second U.S.-based hire, following its Chicago-based vice president of U.S. operations as the company advances its plans to establish a U.S.-based subsidiary.

Alperin brings decades of experience in physician-focused technology solutions, digital medtech product development and a deep understanding of the unique U.S. market landscape. His background includes helping develop the mobile drug reference platform Epocrates, and a tenure as vice president of Product at Doximity, a digital network for medical professionals in the U.S., used by around 80% of U.S. physicians.

The adoption of remote patient monitoring continues to grow steadily in the U.S. as hospitals and health care systems seek ways to enhance patient care while optimizing resources and reducing costs. Medixine said an additional advantage of its RPM platform is its ease of integration and scalability as a white-label solution. This allows hospitals and health care organizations to quickly and cost-effectively deploy digital remote monitoring tools into their existing operations under their own trusted brand identity—a key factor in the competitive U.S. healthcare market.

“Remote patient monitoring is transforming health care delivery in the United States, particularly in addressing critical challenges like rural health care access and chronic condition management,” said Alperin. “Building a digital service solution from scratch can take months or even years of development, testing, and deployment. What drew me to Medixine, along with its physician- and patient-centric approach, is the platform’s ability to strengthen hospital-patient relationships as a tested, reliable white-label offering. This is especially important for health care providers in the U.S., where maintaining brand continuity is crucial for patient trust and engagement. I’m excited to help expand Medixine’s impact and bring its innovative technology to a wider audience.”

As an accomplished physician and Assistant Professor at the University of Texas, Alperin’s understanding of the challenges faced by health care providers is another key asset. His expertise in physician-technology interface and digital health tech product development complement Medixine’s commitment to creating RPM services that improve patient care, comfort and convenience while streamlining and optimizing clinical workflows.

“We see the U.S. as a key market for Medixine, and Peter’s appointment is another strategic step in accelerating our expansion,” Rousi continues. “His extensive experience in both clinical practice and health care technology, combined with his track record in scaling up successful health care platforms, will be invaluable in guiding our efforts. We’re particularly excited to see how his insights will help us further develop our offering to meet the unique needs of U.S. health care providers.”